ClinicalTrials.gov
ClinicalTrials.gov Menu

Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00235703
Recruitment Status : Completed
First Posted : October 10, 2005
Last Update Posted : May 5, 2006
Sponsor:
Information provided by:
University of Utah

Brief Summary:
This is a four-year study, funded by the Center for Disease Control and Prevention, related to antimicrobial resistance in rural communities. The project consists of four components: A) surveillance of antimicrobial resistance, B) promotion of appropriate antimicrobial drug prescribing, C) preliminary assessment of the environmental impact of antimicrobials, and D) the development of new antimicrobial products. Six rural communities in Utah, and six rural communities in Idaho are participating in this study. Component D is being performed by investigators at Harvard University, under the direction of Co-Investigator Roger Inouye.

Condition or disease Intervention/treatment
Upper Respiratory Infections Device: Antimicrobial Prescribing Decision Support

Study Type : Observational
Enrollment : 13000 participants
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective
Official Title: Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)
Study Start Date : October 2001
Study Completion Date : September 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Antibiotics
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Suspected upper respiratory infection patients in 12 rural communities in Utah and Idaho

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00235703


Sponsors and Collaborators
University of Utah
Investigators
Principal Investigator: Matthew H. Samore, MD University of Utah

Publications of Results:
ClinicalTrials.gov Identifier: NCT00235703     History of Changes
Other Study ID Numbers: RS1/CCR820631-01
First Posted: October 10, 2005    Key Record Dates
Last Update Posted: May 5, 2006
Last Verified: October 2005

Additional relevant MeSH terms:
Respiratory Tract Infections
Infection
Respiratory Tract Diseases
Anti-Infective Agents
Anti-Bacterial Agents